Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial
Michael J. Dickinson, Leanne Berkahn, Judith Trotman, Jason Butler, Mathias Bressel, Paul Neeson, Adrian G. Minson British Journal of Haematology
· Wiley
· 2026-11-10
· DOI: 10.1111/bjh.70777
The publisher did not provide an abstract — full text is available via the link below.
Michael J. Dickinson, Leanne Berkahn, Judith Trotman, Jason Butler, Mathias Bressel, Paul Neeson et al. Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial. // British Journal of Haematology. – 2026. – DOI: 10.1111/bjh.70777. – URL: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70777?af=R
Michael J. Dickinson, Leanne Berkahn, Judith Trotman, Jason Butler, Mathias Bressel, Paul Neeson, & Adrian G. Minson (2026). Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial. British Journal of Haematology. https://doi.org/10.1111/bjh.70777
Michael J. Dickinson, et al. “Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial.” British Journal of Haematology, 2026. doi:10.1111/bjh.70777.
@article{Dickinson2026,
title = {Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial},
author = {Dickinson, Michael J. and Berkahn, Leanne and Trotman, Judith and Butler, Jason and Bressel, Mathias and Neeson, Paul and Minson, Adrian G.},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70777},
url = {https://onlinelibrary.wiley.com/doi/10.1111/bjh.70777?af=R}
}